Sort by
Refine Your Search
-
, image analysis and tissue biology. Experience in the tumour microenvironment and immune oncology is essential. You will have an excellent publication track record and have the ability to manage your own
-
), based at the Centre for Human Genetics, University of Oxford. The post aims to assist with the preparation and molecular characterisation of tumours using multi-omic analysis focusing principally
-
is fixed term for up to 36 months with a start date on or before 1st October 2025. This post will involve developing analysis and control methods for systems described by PDEs, with applications in
-
science, with applications to public and veterinary health, therapeutic development, and pandemic preparedness. You will contribute to method development, data analysis, and collaborative projects, and will
-
products (e.g. transcripts and proteins) and imaging analysis. The roles of relevant parasite genes and pathways are investigated using gene expression perturbation approaches, such as RNA interference and
-
supported-lipid bilayers and performing Total Internal Reflection Fluorescence (TIRF) microscopy, together with advanced skills in quantitative image analysis. You will have experience isolating T lymphocytes
-
background in Linguistics, and be willing to work in a Linguistically oriented environment. The post holder must have experience with EEG and should be able to carry out EEG acquisition and analysis of EEG
-
optimising the performance of the vertex detector design for LHCb Upgrade II. Physics analysis is possible, if time allows. Applicants should hold, or be close to completing, a doctoral degree in experimental
-
-on experience in at least one of single-cell or spatial omics, imaging, or other high-dimensional biological data types. You interrogate existing literature critically, design rigorous experiments and deliver
-
. The research is primarily translational in nature, involving both preclinical models and human sample analysis from clinical trials, and is carried out in close collaboration with the pharmaceutical industry